Xencor Inc (NASDAQ:XNCR)
| 32.16 Delayed Data As of Aug 07 |  +0.14 / +0.44%Today’s Change | 19.35 Today|||52-Week Range 42.28 | -6.48% Year-to-Date |
Latest XNCR News | Press Releases
No recent news for Xencor Inc.
Today’s Trading
| Previous close | 32.02 |
| Today’s open | 31.70 |
| Day’s range | 31.70 - 32.93 |
| Volume | 14,200 |
| Average volume (3 months) | 467,437 |
| Market cap | $1.7B |
Data as of 3:59pm ET, 08/07/2020
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -459.29% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +285.93% |
| P/E ratio | NM |
| Price/Sales | 12.83 |
| Price/Book | 2.88 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AUPHAurinia Pharmaceutic... | +0.45 | +3.17% |
| QUREUniqure NV | -0.64 | -1.53% |
| SGMOSangamo Therapeutics... | +0.61 | +5.20% |
| DRNADicerna Pharmaceutic... | +1.02 | +5.10% |
Data as of 6:19pm ET, 08/07/2020
Financials
| Next reporting date | November 10, 2020 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $156.7M |
| Annual profit (last year) | $26.9M |
| Net profit margin | 17.15% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Monrovia, California |
Forecasts
